Results 91 to 100 of about 5,121,825 (181)

The TRIM-cancer paradox: BCG as a programmable vaccine platform and a mechanistic probe for rational immunotherapy design. [PDF]

Front Immunol
Pleshkan VV, Kondratyeva LG, Zinovyeva MV, Bezborodova OA, Alekseenko IV, Shegay PV, Kaprin AD.   +6 more
europepmc   +1 more source

A time-delayed mathematical framework for analyzing pertussis transmission dynamics. [PDF]

Sci Rep
Raza A, Lampart M, Rocha EM, Sumelka W, Fadhal E, Alfwzan WF.   +5 more
europepmc   +1 more source

Anhydrobiosis as a Model of Aging and Longevity: The Role of Autophagy and Metabolism in Yeast Cells. [PDF]

Microb Ecol
Jonnagiri NPKR, Kieliszek M.
europepmc   +1 more source

The emergence of a highly pathogenic marek's disease virus featuring newly identified mutations in Meq oncogene in Southern China. [PDF]

Virol J
Luo Q, Li H, Ge Z, Chen Z, Chen R.
europepmc   +1 more source

²¹¹At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges. [PDF]

Eur J Nucl Med Mol Imaging
Levillain H, Moës AR, Gameiro-Paris C, Abrunhosa A, Deakin T, Gebhart G, Herth MM, Gestin JF, Haddad F, Jensen AI, Bue RL, Mikolajczak R, Otamendi A, Staunton-Mann K, Tabury K, Flamen P, Accelerate.EU consortium.   +16 more
europepmc   +1 more source

A Field Experiment of Marek's Disease Vaccine

Journal of the Japan Veterinary Medical Association, 1973
YAMADA, S., UCHINUNO, Y., KODA, Y., TOKIYOSHI, S., FUJIKAWA, H., MIZUNO, K., OBARA, H., ICHIHARA, T., HATA, A., ABE, H.   +9 more
openaire   +2 more sources

Role of the multiple telomeric repeat arrays in integration, persistence, and efficacy of the commercial CVI988 vaccine. [PDF]

mSphere
Bertzbach LD, You Y, Vychodil T, Kheimar A, Kossak L, Sabsabi MA, Conradie AM, Kaufer BB.   +7 more
europepmc   +1 more source

Immune persistence and safety of the AS01_E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. [PDF]

Hum Vaccin Immunother
Ferguson M, Schwarz TF, Núñez SA, Rodríguez-García J, Mital M, Zala C, Pek B, Schmitt B, Toursarkissian N, Ochoa Mazarro D, Großkopf J, Voors-Pette C, Mehta H, Amare Hailemariam H, Gérard C, Damaso S, David MP, Descamps D, Hill J, Vandermeulen C, Hulstrøm V.   +20 more
europepmc   +1 more source

Trials in progress: CARMAN - study protocol of a randomized controlled, international, multicenter, open-label phase II trial evaluating early treatment intensification in patients with high-risk mantle cell lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with rituximab and ibrutinib and 6 months ibrutinib maintenance as compared to standard of care induction and maintenance. [PDF]

BMC Cancer
Tilch MK, Schmidt C, Trneny M, Giné E, Hermine O, Ohler A, Herold S, Hoster E, Jiang L, Pott C, Dreyling M, Hess G.   +11 more
europepmc   +1 more source

Ferritin Nanocages Exhibit Unique Structural Dynamics When Displaying Surface Protein. [PDF]

Int J Mol Sci
Padariya M, Marek-Trzonkowska N, Kalathiya U.   +2 more
europepmc   +1 more source